Home / Roles / Occupations / 13-1111 / NY / FY2025
SOC 13-1111 H-1B roles in NY, FY2025
SOC-coded LCA role declarations for occupation 13-1111 in NY during FY2025. Rows include employer, title, worksite, status, decision date, offered wage, prevailing wage, and source evidence. Showing 10 returned rows using keyset pagination.
| Role | Employer | SOC | Status / visa | Decision | Worksite | Offered wage | Prevailing wage | Source |
|---|---|---|---|---|---|---|---|---|
| Business Architecture Manager I-200-25174-119283 | Accenture LLP | 13-1111 Management Analysts | Certified / H-1B FY2025 | 2025-06-30 2025-11-24 to 2028-11-23 | New York, NY, 10041 | $169,400 to $338,400 year | $159,682 | sr_dol_oflc_lca_2025_q3_row_000261 |
| Associate Director I-200-25164-089155 | Board of Innovation US Inc. | 13-1111 Management Analysts | Certified / H-1B FY2025 | 2025-06-23 2025-10-01 to 2028-09-30 | New York, NY, 10013 | $160,000 year | $159,682 | sr_dol_oflc_lca_2025_q3_row_024084 |
| Senior Manager I-203-25143-012180 | Macquarie Investment Management Advisers | 13-1111 Management Analysts | Certified / E-3 Australian FY2025 | 2025-06-02 2025-07-31 to 2027-07-30 | New York, NY, 10103 | $160,000 to $180,000 year | $159,682 | sr_dol_oflc_lca_2025_q3_row_080356 |
| Senior Manager I-203-25143-012156 | Macquarie Investment Management Advisers | 13-1111 Management Analysts | Withdrawn / E-3 Australian FY2025 | 2025-05-23 2025-07-31 to 2027-07-30 | New York, NY, 10103 | $160,000 to $180,000 year | $159,682 | sr_dol_oflc_lca_2025_q3_row_100436 |
| Manager, Corporate & Portfolio Strategy I-200-25136-987281 | IQVIA Inc. | 13-1111 Management Analysts | Certified / H-1B FY2025 | 2025-05-23 2025-06-02 to 2028-06-01 | New York, NY, 10022 | $188,900 to $277,300 year | $159,682 | sr_dol_oflc_lca_2025_q3_row_102131 |
| Manager, Strategy/Life Sciences I-200-25135-979369 | Cambridge Pharma Consulting Inc. | 13-1111 Management Analysts | Certified / H-1B FY2025 | 2025-05-22 2025-10-01 to 2028-09-30 | New York, NY, 10022 | $201,600 to $277,300 year | $159,682 | sr_dol_oflc_lca_2025_q3_row_105417 |
| Manager, Strategy/Life Sciences I-200-25128-953620 | Cambridge Pharma Consulting Inc. | 13-1111 Management Analysts | Certified / H-1B FY2025 | 2025-05-15 2025-10-01 to 2028-09-30 | New York, NY, 10022 | $181,700 to $277,300 year | $159,682 | sr_dol_oflc_lca_2025_q3_row_126994 |
| Vice President I-200-25087-812739 | BlackRock Financial Management, Inc. | 13-1111 Management Analysts | Certified / H-1B FY2025 | 2025-04-04 2025-09-09 to 2028-09-08 | New York, NY, 10001 | $187,100 year | $131,706 | sr_dol_oflc_lca_2025_q3_row_230925 |
| Management Consulting Manager I-200-25087-810223 | Accenture LLP | 13-1111 Management Analysts | Certified / H-1B FY2025 | 2025-04-04 2025-09-27 to 2028-09-26 | New York, NY, 10011 | $194,800 to $338,400 year | $159,682 | sr_dol_oflc_lca_2025_q3_row_231720 |
| Solutions Lead I-200-25071-767332 | LEE HECHT HARRISON LLC | 13-1111 Management Analysts | Certified / H-1B FY2025 | 2025-03-18 2025-03-17 to 2028-03-16 | New York, NY, 10010 | $125,000 to $135,000 year | $103,709 | sr_dol_oflc_lca_2025_q2_row_021525 |
End of returned pageReset
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/roles?limit=50&soc_code=13-1111&state=NY&fiscal_year=2025JSON